• No results found

Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target

N/A
N/A
Protected

Academic year: 2020

Share "Annexin A3 is a mammary marker and a potential neoplastic breast cell therapeutic target"

Copied!
7
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1: Bottom up proteomic analysis identified ANX A3 as a potential breast cancer marker
Figure 2: Immuno-validation and tissue correlation of ANX A3. a. ANX A3 levels in pooled serum fractions measured by quantitative ELISA

References

Related documents

This double-blind randomised controlled trial is designed to investigate the effect of glutamine-enriched enteral nutrition on feeding tolerance, infectious morbidity and

For dual task walking, three different types of tasks were used: walking while (1) counting forward, (2) serially subtracting, and (3) reciting digit spans.. These tasks were

Methods: We conducted a case-control study to examine the association of common genetic variants in the genes coding for ghrelin (GHRL) and its receptor (GHSR) with colorectal

Pearson, PEACEKEEPERS replaced French and British troops to protect the canal and keep Israel and Egypt apart..

Conclusions: The simultaneous presence of globin synthesis abnormalities and panhypogammaglobu- linemia suggests that a common insult at the stem cell level could contribute to

In this paper, we primarily focus on the analysis of re- cently proposed pairing delegation schemes, and design the first fully verifiable secure delegation scheme VerPair for

Objective: To report the in vivo laser confocal microscopy findings of a cornea with osteogenesis imperfecta (OI) with special attention to the abnormality of

The progress in many areas of life and in the various fields of science, through the use of modern scientific instruments developed in all fields (such as knowledge of